ERO1LB Antikörper
Kurzübersicht für ERO1LB Antikörper (ABIN7113880)
Target
Alle ERO1LB Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- ERO1B antibody
-
Aufreinigung
- Immunogen affinity purified
-
Reinheit
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- ERO1-like beta
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB: 1:500-1:2000, IHC: 1:20-1:200, IF: 1:50-1:500
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze / thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C for 12 months
-
Haltbarkeit
- 12 months
-
-
- ERO1LB (ERO1-Like beta (ERO1LB))
-
Andere Bezeichnung
- ERO1B
-
Hintergrund
-
Synonyms: ERO1-like protein beta (ERO1-L-beta)|Endoplasmic reticulum oxidoreductase beta|Endoplasmic reticulum oxidoreductin-1-like protein B|Oxidoreductin-1-L-beta|ERO1B|ERO1LB
Background: Endoplasmic reticulum oxidoreductases (Eros) are essential for the formation of disulfide bonds. Mammals express two related Ero proteins, Ero1L alpha and Ero1L beta. The two homologous proteins can form homodimers and mixed heterodimers. ERO1-Lα and -β are highly expressed in organs with a high demand for secretion, consistent with their roles in oxidative folding of ER proteins.
-
Molekulargewicht
- 40~50 kDa
-
Gen-ID
- 56605
-
UniProt
- Q86YB8
-
Pathways
- SARS-CoV-2 Protein Interaktom
Target
-